Insider Transactions in Q1 2025 at Amylyx Pharmaceuticals, Inc. (AMLX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 05
2025
|
Justin B. Klee Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
36,310
+1.12%
|
$36,310
$1.57 P/Share
|
|
Feb 03
2025
|
Joshua B Cohen Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
11,851
-0.37%
|
$35,553
$3.47 P/Share
|
|
Feb 03
2025
|
Gina Mazzariello Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,678
-2.58%
|
$11,034
$3.49 P/Share
|
|
Feb 03
2025
|
Justin B. Klee Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
11,855
-0.37%
|
$35,565
$3.47 P/Share
|
|
Jan 24
2025
|
George M Milne Jr |
SELL
Bona fide gift
|
Direct |
27,910
-3.25%
|
-
|
|
Jan 06
2025
|
Justin B. Klee Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
7,471
-0.23%
|
$29,884
$4.04 P/Share
|
|
Jan 06
2025
|
Joshua B Cohen Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
7,471
-0.23%
|
$29,884
$4.05 P/Share
|